NorthRock Partners LLC Has $266,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

NorthRock Partners LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 42.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 655 shares of the company’s stock after selling 492 shares during the quarter. NorthRock Partners LLC’s holdings in HCA Healthcare were worth $266,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. CreativeOne Wealth LLC bought a new position in shares of HCA Healthcare in the 1st quarter worth $231,000. Bessemer Group Inc. lifted its holdings in shares of HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after purchasing an additional 2,584 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of HCA Healthcare by 54.3% in the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after purchasing an additional 4,893 shares in the last quarter. Swedbank AB bought a new position in shares of HCA Healthcare in the 1st quarter worth $95,882,000. Finally, EP Wealth Advisors LLC lifted its stake in HCA Healthcare by 1.6% during the 2nd quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock valued at $72,335,000 after acquiring an additional 3,516 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. KeyCorp decreased their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $379.39.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $348.50 on Thursday. The company has a market cap of $88.28 billion, a PE ratio of 15.65, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a 50-day moving average price of $391.18 and a 200-day moving average price of $355.72. HCA Healthcare, Inc. has a 12-month low of $226.48 and a 12-month high of $417.14.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.